2019 - Fellow of the Royal Society of Canada Academy of Science
The scientist’s investigation covers issues in Psychiatry, Major depressive disorder, Clinical psychology, Bipolar disorder and Internal medicine. Psychiatry is a component of his Mood, Depression, Comorbidity, Major depressive episode and Treatment-resistant depression studies. His Major depressive disorder research incorporates elements of Venlafaxine, Antidepressant, Tolerability, Randomized controlled trial and Evidence-based medicine.
His Clinical psychology study combines topics in areas such as Cognitive therapy, Cognition, Neuroimaging, Mental health and Family history. His Bipolar disorder study deals with Mood disorders intersecting with Frontal lobe. His studies in Internal medicine integrate themes in fields like Positron emission tomography, Endocrinology and Cardiology.
His scientific interests lie mostly in Psychiatry, Major depressive disorder, Depression, Internal medicine and Clinical psychology. Many of his studies on Psychiatry apply to MEDLINE as well. His Major depressive disorder research is multidisciplinary, incorporating elements of Antidepressant, Escitalopram, Rating scale, Tolerability and Major depressive episode.
His Antidepressant research includes elements of Randomized controlled trial and Pharmacology. His biological study deals with issues like Placebo, which deal with fields such as Agomelatine. The study incorporates disciplines such as Anhedonia, Quality of life, Cognition, Neuroimaging and Personality in addition to Clinical psychology.
Sidney H. Kennedy mainly investigates Major depressive disorder, Depression, Internal medicine, Clinical psychology and Antidepressant. Major depressive disorder is a subfield of Psychiatry that Sidney H. Kennedy studies. Sidney H. Kennedy combines subjects such as Meta-analysis and MEDLINE with his study of Psychiatry.
His Internal medicine research also works with subjects such as
His primary scientific interests are in Major depressive disorder, Depression, Internal medicine, Clinical psychology and Antidepressant. His Major depressive disorder study is related to the wider topic of Psychiatry. His work deals with themes such as Rating scale, Treatment outcome, Chronic pain, Neuroimaging and National Health and Nutrition Examination Survey, which intersect with Depression.
The concepts of his Internal medicine study are interwoven with issues in Escitalopram and Cardiology. Sidney H. Kennedy interconnects Quality of life, Bipolar disorder, Mood disorders and Schizophrenia in the investigation of issues within Clinical psychology. His Antidepressant research incorporates themes from Genome-wide association study, Duloxetine, Prefrontal cortex, Functional neuroimaging and Pharmacology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Deep brain stimulation for treatment-resistant depression.
Helen S. Mayberg;Helen S. Mayberg;Andres M. Lozano;Valerie Voon;Heather E. McNeely.
Modulation of cortical-limbic pathways in major depression: treatment-specific effects of cognitive behavior therapy.
Kimberly Goldapple;Zindel Segal;Carol Garson;Mark Lau.
Archives of General Psychiatry (2004)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2013.
Lakshmi N. Yatham;Sidney H. Kennedy;Sagar V. Parikh;Ayal Schaffer.
Bipolar Disorders (2013)
Limbic-frontal circuitry in major depression: a path modeling metanalysis.
David A. Seminowicz;Helen S. Mayberg;Anthony R. McIntosh;K. Goldapple.
Bulimia nervosa in a Canadian community sample: prevalence and comparison of subgroups.
Garfinkel Pe;Lin E;Goering P;Spegg C.
American Journal of Psychiatry (1995)
Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression.
Sidney H. Kennedy;Kenneth R. Evans;Stephanie Krüger;Helen S. Mayberg.
American Journal of Psychiatry (2001)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009
Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh.
Bipolar Disorders (2009)
Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder
Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer.
Bipolar Disorders (2018)
Cognitive reactivity to sad mood provocation and the prediction of depressive relapse.
Zindel V. Segal;Sidney Kennedy;Michael Gemar;Karyn Hood.
Archives of General Psychiatry (2006)
Canadian Network for Mood and Anxiety Treatments (CANMAT) Clinical guidelines for the management of major depressive disorder in adults
Sidney H. Kennedy;Raymond W. Lam;Sagar V. Parikh;Scott B. Patten.
Journal of Affective Disorders (2009)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: